Company / SG&A per Share
AETHLON MEDICAL INC SG&A per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.41
FY2024
5-year range
$0.17 / $1.41
FY2020-FY2024
Trend
+457.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +457% YoY in FY2024, a notable deviation from the 9-year average annual change of +710%.
Based on SEC 10-K filings.
1.41 in FY2024 with a 10-year CAGR of +78.5%.
Increased from $0.37 to $1.41 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +104.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- +78.5%
Key checks
Key Insights
- In FY2024, sg&a per share increased 457.2% year-over-year.
- Lowest sg&a per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.41 | +457.2% |
| FY2023 | $0.25 | -31.4% |
| FY2022 | $0.37 | +123.1% |
| FY2021 | $0.17 | -78.0% |
| FY2020 | $0.75 | +1300.1% |
| FY2018 | $0.05 | -55.9% |
| FY2017 | $0.12 | -4.5% |
| FY2016 | $0.13 | -38.3% |
| FY2015 | $0.21 | +4717.0% |
| FY2014 | $0.00 | -40.8% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026